Executive Profile

David C. U'Prichard Ph.D. President of Industry Consultants, Druid Consulting, LLC

Age	Total Calculated Compensation	This person is connected to 14 Board Members in 14 different organizations across 20 different industries. See Board Relationships
63	--

Background

Dr. David C. U'Prichard, Ph.D. serves as Chief Scientific Officer of BioMotiv LLC. Dr. U'Prichard has been the President of Industry Consultants at Druid Consulting LLC since 2003. He is Investment Professional of Druid BioVentures and also has been a Founding Partner of Druid Bio Ventures LLP since 2009. He has been with BioMotiv since 2012. He is a Strategic Partner of Dapis Capital LLC. He joined Dapis in 2009. He was a Venture Partner of Red Abbey Venture Partners ... LLC from January 2005 to 2010 and as its Senior Advisor of Scientific Advisory Board since January 2004. He has successful healthcare investing and renowned expertise in the areas of biopharmaceutical development and research tools. From 2003 to 2006, he was a Venture Partner of Apax Partners LLP (Alternate Name: Apax Partners Worldwide LLP) and Care Capital, LLC. He was a Member of the Health Care Team at Apax Partners LLP. He served as the Chief Executive Officer of 3-Dimensional Pharmaceuticals Inc., (“3DP“) from September 1999 to 2003. From 1997 to 1999, he served as the President and Chairman of Research and Development at SmithKline Beecham Limited (Pharmaceuticals). Previously, he had been with ICI/Zeneca from 1986 to 1997, including served as its Executive Vice President and International Research Director from 1994 to 1997. Dr. U'Prichard served as a General Manger of Research Department at ICI Pharmaceuticals from 1991 to 1994 and Vice President of Biomedical Research at ICI Pharmaceuticals from 1986 to 1991. He served as a Senior Vice President and Scientific Director of Nova Pharmaceutical Corporation from 1983 to 1986. He co-founded Nova Pharmaceutical Corp., in 1983 and served as its Head of Research and Development. He served as an Executive Vice President and International Research Director of Zeneca Pharmaceuticals Group from 1994 to 1997. He serves as the Chairman of Cyclacel Pharmaceuticals Inc. He serves as Chairman of Scientific Advisory Board at BioMotiv, LLC. He served as the Chairman of Oxagen Limited from 2004 to 2011. He served as the Chairman of Xcyte Therapies Inc. He served as the Chairman of The Pennsylvania Biotechnology Association from 2004 to 2005. He has been a Director of Audeo Oncology Inc., since September 28, 2012. He has been a Non-Executive Director of Cyclacel Pharmaceuticals Inc., since May 2004. He serves as a Member of Board of Managers at BioMotiv, LLC. Dr. U'Prichard serves as a Director of Invitrogen Corp., and Angstrom Pharmaceuticals Inc. He serves as a Member of Scientific Advisory Board at Corridor Pharmaceuticals Inc. He has been a Director of Life Technologies Corporation since April 2004 and Life Technologies Inc., since May 2004; Iroko Pharmaceuticals LLC since November 17, 2010, Ocimum Biosolutions Ltd., since March 8, 2010 and Cyclacel since May 2004. He serves on the Boards of the Biotechnology Greenhouse of Southeastern Pennsylvania and the Bioethics Institute of the University of Pennsylvania. He serves as a Director and Member of Scientific Advisory Board at Naurex, Inc. He serves as a Member of the Scientific Advisory Board at Advinus Therapeutics Limited (Alternate Name: Advinus Therapeutics Private Limited) and American Oriental Bioengineering AOBO. He served as a Director of 3-Dimensional Pharmaceuticals Inc., from September 1999 to 2003; Anesiva Inc., since November 23, 2009 and Alpharma Inc., from June 2007 to December 2008. He served as a Director of Lynx Therapeutics Inc., from March 2001 to 2006. Dr. U'Prichard served as a Non Executive Director of Silence Therapeutics Plc from 2004 to 2011. He served as a Director of ExSAR, Predict Inc., RiboTargets Holdings Plc, and SMART Biosciences Inc. He served as a Director of BioAdvance. He served as a Director of Xcyte Therapies Inc., since May 2004. He served as a Director of the Biotechnology Industry Organization (BIO) from 1992 to 1997. He served as a Director of Oxagen Limited since May 2004, Guilford Pharmaceuticals Inc., from November 18, 2003 to 2005 and Teva Biopharmaceuticals USA Inc. (Alternate Name: Cogenesys Inc.) since December 19, 2006. He served as a Director of Ben Franklin Technology Partners of Southeastern Pennsylvania, Investment Arm. He served as a Member of the Development Advisory Board at Oxagen Limited. Dr. U'Prichard served as a Member of Scientific Advisory Board at TetraLogic Pharmaceuticals Inc. He is an Honorary Professor of the University of Glasgow. He has held academic appointments at Northwestern University and Johns Hopkins University. He served as a Director of Bioethics Institute at the University of Pennsylvania. He was a Associate Professor of Pharmacology and Neurobiology at Northwestern University Medical School from 1978 to 1983. He was a Founding Co-Editor of Molecular Neurobiology and Co-Editor of Epinephrine in the Central Nervous System. He serves as a Trustee of the International House of Philadelphia. He is an Author of more than 100 primary and review publications. Dr. U'Prichard holds a Ph.D. in 1975 and an MS in Pharmacology from the University of Kansas and a BS in Pharmacology with first-class honors from the University of Glasgow, Scotland. He has completed Post-Doctoral Training at Johns Hopkins University in 1978.

Corporate Headquarters 121 Pine Street Philadelphia, Pennsylvania 19106 United States Phone: 215-928-9226 Fax: 215-925-2282 Board Members Memberships Former Director Ben Franklin Technology Partners of Southeastern Pennsylvania, Investment Arm Former Director RiboTargets Holdings plc Former Non-Executive Director, Chairman of Nominations & Governance Committee, Member of Audit Committee and Member of Remuneration Committee Silence Therapeutics plc President and Chairman, Research and Development SmithKline Beecham Limited Director Predict, Inc. Director Angstrom Pharmaceuticals, Inc. Director of Bioethics Institute University of Pennsylvania Director BioAdvance Chairman The Pennsylvania Biotechnology Association Director Smart Biosciences, Inc. Director and Member of Scientific Advisory Board Naurex, Inc. Chairman of Scientific Advisory Board, Chief Scientific Officer and Member of Board of Managers BioMotiv, LLC 1999-N/A Former Chief Executive Officer and Director 3-Dimensional Pharmaceuticals, Inc. 2001-N/A Former Director and Member of Audit Committee Lynx Therapeutics Inc. 2003-N/A Former Director, Member of Compensation Committee and Member of Science Committee Guilford Pharmaceuticals Inc. 2004-Present Director, Chairman of Regulatory Oversight Committee, Member of Compensation & Organizational Development Committee and Member of Science & Technology Committee Life Technologies Corporation 2004-Present Chairman, Member of Compensation & Organizational Development Committee and Member of Nominating & Corporate Governance Committee Cyclacel Pharmaceuticals, Inc. 2004-N/A Former Chairman and Member of the Development Advisory Board Oxagen Limited 2004-N/A Former Chairman and Member of Compensation Committee Xcyte Therapies Inc. 2006-Present Director Teva Biopharmaceuticals USA, Inc. 2007-2008 Former Director and Member of Nominating & Corporate Governance Committee Alpharma, Inc. 2009-N/A Former Director Anesiva, Inc. 2010-Present Director Ocimum Biosolutions, Ltd. 2010-Present Member of the Board Iroko Pharmaceuticals, LLC 2012-Present Director Audeo Oncology, Inc. Education MS University of Kansas PhD 1975 University of Kansas BS University of Glasgow Scotland Post-Doctoral Training 1978 Johns Hopkins University Other Affiliations Apax Partners LLP Ben Franklin Technology Partners of Southeastern Pennsylvania, Investment Arm 3-Dimensional Pharmaceuticals, Inc. Life Technologies Corporation Lynx Therapeutics Inc. Guilford Pharmaceuticals Inc. Cyclacel Pharmaceuticals, Inc. Oxagen Limited RiboTargets Holdings plc Silence Therapeutics plc Alpharma, Inc. SmithKline Beecham Limited Care Capital, LLC Predict, Inc. Anesiva, Inc. Nova Pharmaceutical Corp Angstrom Pharmaceuticals, Inc. University of Pennsylvania Johns Hopkins University University of Kansas Audeo Oncology, Inc. BioAdvance University of Glasgow Scotland The Pennsylvania Biotechnology Association Xcyte Therapies Inc. Zeneca Pharmaceuticals Group Ocimum Biosolutions, Ltd. Red Abbey Venture Partners, LLC TetraLogic Pharmaceuticals, Inc. Teva Biopharmaceuticals USA, Inc. Advinus Therapeutics Limited Iroko Pharmaceuticals, LLC Corridor Pharmaceuticals, Inc. Smart Biosciences, Inc. Dapis Capital LLC Naurex, Inc. Druid BioVentures BioMotiv, LLC

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.